Ovid Therapeutics Inc. (OVID) Capital expenditures 2016–2025
Ovid Therapeutics Inc. (OVID) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$0FY2025 · since FY2016: $30,364 → $0
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $0 | -100.0% |
| FY2024 | $71,000 | +77.5% |
| FY2023 | $40,000 | -96.7% |
| FY2022 | $1.2M | +565.4% |
| FY2021 | $184,008 | +44.6% |
| FY2020 | $127,240 | +122.6% |
| FY2019 | $57,156 | +68.7% |
| FY2018 | $33,871 | -12.9% |
| FY2017 | $38,907 | +28.1% |
| FY2016 | $30,364 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice